Novel PLEC-EML4-ALK Double Fusion Underlying Crizotinib Resistance in a Metastatic Inflammatory Myofibroblastic Tumor: A Case Report by Alessandra Maleddu, MD, Trista K. Hinz, MS, Margaret A. Black, MD, Dara L. Aisner, MD, PhD, Carrie B. Marshall, MD, Anthony D. Elias, MD, Breelyn A. Wilky, MD, Lynn E. Heasley, PhD, Kurtis D. Davies, PhD

Get full text